Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sambhaji Deshmukh"'
Publikováno v:
Indian Research Journal of Pharmacy and Science. 6:1825-1831
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::348c78c27fcbb4cef2973d4f803c4f13
https://doi.org/10.21276/irjps.2019.6.1.8
https://doi.org/10.21276/irjps.2019.6.1.8
Autor:
Alok Pote, Santhanam Ravisankar, Ganesh Sangle, Sunil Agarwal, Viresh Yarramshetti, Sushil Kale, M. L. A. Baig, Sambhaji Deshmukh, Ruchi Shah, Khokan Debnath, Kishor Chitalkar, Pankaj Adsare, Shahu Ingole
Background- Among the gliptins, vildagliptin is the only therapy requiring twice-daily dosing and thus adversely impacts patient adherence. To reduce dosing frequency, we developed a once-daily sustained-release (SR) vildagliptin 100 mg tablet formul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::b9689bedff470a92aba4df5e990f19e7
https://zenodo.org/record/4841121
https://zenodo.org/record/4841121
